An Inspiring Couple Working to Help Find a Cure for Cancer

HENRY SU AND KIMMIE NG ARE NO STRANGERS TO CANCER RESEARCH. HENRY IS A RADIOLOGIST AND HIS WIFE KIMMIE IS A GASTROINTESTINAL ONCOLOGIST.

An Inspiring Couple Working to Help Find a Cure for Cancer

Henry Su and Kimmie Ng are no strangers to Cancer Research. Henry is a radiologist and images patients with cancer every day. Sometimes he never speaks to the patient but knows within seconds the diagnosis, the type of cancer, the treatment, and whether it’s getting better or worse. If the findings are consistent with malignancy, he is the first to know. It is never easy for him to report this news.

Henry Su Team Fear Nothing Team shot

His wife Kimmie is a gastrointestinal oncologist at Dana-Farber who, along with a team of doctors, has led research on patients being treated for non-metastatic stage III colon cancer. They have made some amazing breakthroughs, linking a healthy diet to an increased rate of survival in patients that have undergone surgery for colon cancer and chemotherapy. Specifically, patients who ate a Mediterranean-style diet, rich in vegetables, fruits, legumes, and healthy fats and proteins, produce lower insulin levels and had a lower recurrence of the disease than those patients who ate a Western-style diet that is high in simple carbohydrates, sugar and fat, leading to higher insulin levels.

Team Fear Nothing Dana Farber shot w check

 

In a Dana-Farber Cancer Institute News release Kimmie said, “The findings that patients with the highest dietary insulin load had twice the risk of colon cancer recurrence and death as those with the lowest load underscores the role patients themselves can play in helping to reduce their risk. Patients are always interested in what they can do to reduce their risk of cancer recurrence and we now have dietary advice that, our research shows, may make a difference.” Further research using high doses of Vitamin D, Personalized Medicine and Immunotherapy have led to major advancements for Kimmie’s team.

With research comes funding restrictions, so Kimmie and her team use philanthropic money for much of their work. This inspired Henry to join Pan-Mass Challenge (PMC) “Team Fear Nothing” in 2013. The team was formed by the son of one of Kimmie’s patients that she treated for rectal cancer. One hundred percent of PMC-generated revenue goes to directly support the Jimmy Fund and Dana-Farber Cancer Institute's commitment to finding a cure. To date, Team Fear Nothing has amazingly raised over $500,000 for cancer research. DLFG was honored to sponsor Team Fear Nothing in 2018 and experience first-hand how motivated Kimmie, Henry, and their team of tireless riders and researchers are to finding a cure. As Henry put it “My goal remains simple. I want to be more frequently dictating - No evidence of disease.” Henry and Kimmie are an inspiring couple. We feel blessed to be able to celebrate their accomplishments as they work diligently towards a cure.

Contact
  • Phone :
  • E-Mail:

    This email address is being protected from spambots. You need JavaScript enabled to view it.

OUR OFFICES
  • 5 Burlington Woods, Suite 102
  • Burlington, MA 01803

Check us out


© 2021 DOBLE LEBRANTI FINANCIAL GROUP LLC. All rights reserved.

This communication is strictly intended for individuals residing in the states of CA, CO, CT, FL, IL, IN, MA, MD, ME, NC, NH, NJ, NV, NY, OR, RI, TX, VA, VT. No offers may be made or accepted from any resident outside these states due to various state regulations and registration requirements regarding investment products and services. Investments are not FDIC- or NCUA-insured, are not guaranteed by a bank/financial institution, and are subject to risks, including possible loss of the principal invested. Securities and advisory services offered through Commonwealth Financial Network®, Member FINRA/SIPC, a Registered Investment Adviser.

Fixed insurance products and services offered through Doble LeBranti Financial Group or CES Insurance Agency.

To Check Firm or Individual Backgrounds please go to Finra’s Brokercheck. Powered by AdvisorFlex.